St. Bartholomew's Hospital
Peter Szlosarek is a Professor of Medical Oncology at the Barts Cancer Center and Institute, London, UK. Over the last 25 years he has pioneered the preclinical and clinical development of arginine deprivation in a variety of human cancers including uveal melanoma and mesotheloma with pegargiminase (under FDA review). He works closely with colleagues at Moorfields Eye Hosptial, London and Barts to innovate novel approaches for the treatment of uveal melanoma.
